< Back to latest news & events

Event

Microbiome Movement – Maternal & Infant Health Summit 2020

October 2020

Event date: 15th October 2020

HGF Partner Craig Thomson will be presenting at the Microbiome Movement – Maternal & Infant Health Summit 2020 on 15th October.

The 2nd Microbiome Movement – Maternal & Infant Health Summit returns as the only conference to unite large pharma, drug developers, academic KOL’s and paediatric clinicians to discuss the shared challenges of helping to configure the microbiome in the first 1000 days of life to reduce risk of chronic health conditions.

Join the conference to find out more about the latest data-driven research and hear discussions on how to shape future research to accelerate the field as we begin to unlock the secrets of the infant microbiome to proactively prevent disease.

HGF Partner Craig Thomson will be presenting on Thursday 15th October.

Build a Commercially Relevant Microbiome IP Portfolio: Maternal and Infant Health
  • Understand the multiple motivations for building an IP Portfolio: protect a monopoly of sales, attract investment, improve bargaining position with a collaborator/competitor
  • How to make a commercially relevant selection of what to protect and when
  • How to effectively fit IP strategy into the wider challenges of an innovative microbiome business.

Attendees

Latest updates

Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article